Root Financial Partners’s Nurix Therapeutics NRIX Stock Holding History

Root Financial Partners’s Portfolio NRIX Stock Details NRIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.81K	Buy	+245	New	+$6.11K	﹤0.01%	2166

Other funds holding NRIX

WestHill Financial Advisors San Rafael, California $597M AUM 13.09% 1-Year Est. Return

RAM Investment Partners Bellevue, Washington $631M AUM 11.73% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Root Financial Partners's NRIX Position: Q3 2026 in Review

Root Financial Partners opened a new position in Nurix Therapeutics (NRIX) in Q3 2026: 245 shares worth $5.81K. The stake represents ﹤0.01% of the portfolio and ranks #2166 among its holdings.

14 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.

Root Financial Partners held 245 shares of Nurix Therapeutics worth $5.81K as of Q3 2026.
Nurix Therapeutics was a new Root Financial Partners position in Q3 2026.
Nurix Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2166 holding.
14 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.